MetLife Valuation Overview

MET -- USA Stock  

USD 44.87  0.32  0.71%

MetLife secures last-minute Real Value of $49.78625 per share. The latest price of the firm is $44.87. At this time the firm appears to be under valued. Macroaxis forecasts value of MetLife from analyzing the firm fundamentals such as Current Valuation of 118.14B, Profit Margin of 6.43% and Return On Equity of 8.66% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend to purchase undervalued stocks and to get rid of overvalued stocks since at some point entities prices and their ongoing real values will merge together.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
MetLife Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
MetLife Market Cap
MetLife is regarded second in market capitalization category among related companies. Market capitalization of Insurance - Life industry is now estimated at about 178.12 Billion. MetLife totals roughly 44.58 Billion in market capitalization claiming about 25% of equities under Insurance - Life industry.
Capitalization  Revenue  Total debt  Workforce  Valuation
Horizon     30 Days    Login   to change
MetLife is regarded fifth in beta category among related companies. It is rated below average in price to sales category among related companies fabricating about  0.57  of Price to Sales per Beta. The ratio of Beta to Price to Sales for MetLife is roughly  1.74 

Current Market Valuation

MetLife Valuation Boundaries

Under Valued
November 12, 2018
44.87
Market Value
49.79
Real Value
Target Odds
  
55.88
Upside
MetLife is not too volatile asset. Calculation of real value of MetLife is based on 1 month time horizon. Increasing MetLife time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

MetLife Enterprise Value Fundamentals

Quick Ratio0.84
Earnings Quarterly Growth-2.20%
Revenue Growth38.20%
Payout Ratio32.79%
Enterprise Value To Ebitda19.79
Earnings Growth3.30%
Enterprise Value To Revenue1.74
Please see also Stocks Correlation. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Search macroaxis.com